Drug Type Small molecule drug |
Synonyms ME 1111 |
Target |
Action inhibitors |
Mechanism SDH2 inhibitors(Mitochondrial complex II; succinate dehydrogenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H14N2O |
InChIKeyVQXHPRBERPTLQW-UHFFFAOYSA-N |
CAS Registry1391758-52-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Onychomycosis | Phase 2 | United States | 19 Dec 2013 |





